ESC 365 - Risk stratification of HCM in 2017: the European approach.

EHRA Premium Access

Risk stratification of HCM in 2017: the European approach.

Session: Hypertrophic cardiomyopathy genetics and clinical management

Topic: Molecular biology / genetics

Speaker: Professor P. Elliott (London, GB)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)

67 presentations

28 followers

3 more presentations in this session

Diagnostic and prognostic role of genotyping in HCM.

Speaker: Professor P. Charron (Paris, FR)

Atrial fibrillation and outcome in HCM: the American vs. European approach to risk stratification

Speaker: Professor E. Arbustini (Pavia, IT)

Ablation in HCM.

Speaker: Professor L. Di Biase (The Bronx, US)

Access the full session

Hypertrophic cardiomyopathy genetics and clinical management

Speakers: Professor P. Elliott, Professor P. Charron, Professor E. Arbustini, Professor L. Di Biase

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources